Dear Health Advocates, It was a busy week in the healthcare advocacy world. We testified in front of The Ways and Means Committee, the House Energy and Commerce Committee looked at bills to address dishonest pricing and transparency, and the Fifth Circuit Appeals Court heard arguments on May 17 regarding the Mifepristone case. These arguments followed the Supreme Court's stay on the Fifth Circuit Appeals Court decision. Please continue to sign and share our People's Brief to Protect Mifepristone, which you can find under Action Items. It's important that we continue to stay engaged and speak up for access to lifesaving medications. Also, check out our new video resources on the committee hearing and bill markup as well. Additional resources, events, and items are also below: